drugset / Trial / NCT01046942

ThrombElastoGraphic Haemostatic Status and Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery

NCT01046942

Phase 3 Unknown 250 enrolled Rigshospitalet, Denmark
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether adding clopidogrel to aspirin after coronary bypass operation (CABG) improves graft patency, in patients that have preoperatively increased platelet activity(hypercoagulable) and therefore greater risk of graft occlusion( thrombosis).

Timeline

Start
2008-11
Primary completion
2014-05
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule 75 mg
Subject Clopidogrel Small molecule 75 mg